Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SLGC

SLGC - SomaLogic, Inc. Stock Price, Fair Value and News

$19.92 
Market Closed

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

SLGC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SLGC Price Action

Last 7 days

-0.1%

SLGC RSI Chart

SLGC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SLGC Valuation

SLGC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

SLGC Fundamentals

SLGC Revenue

SLGC Earnings

SLGC Profitability

SLGC Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202395.1M101.4M81.7M0
202285.7M80.1M101.8M97.7M
202162.3M68.8M75.2M81.6M
202000055.9M
Get all data in R, Python etc through our Historical Stock Data APIs

About SomaLogic, Inc.

SLGC
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.
 CEO
 WEBSITEsomalogic.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES451

SomaLogic, Inc. Frequently Asked Questions

SLGC is the stock ticker symbol of SomaLogic, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.